中华口腔医学杂志
中華口腔醫學雜誌
중화구강의학잡지
Chinese Journal of Stomatology
2011年
1期
24-26
,共3页
张大明%陈伟良%柴强%梁衍灿%杨朝晖%李劲松
張大明%陳偉良%柴彊%樑衍燦%楊朝暉%李勁鬆
장대명%진위량%시강%량연찬%양조휘%리경송
癌,鳞状细胞%舌肿瘤%外科皮瓣
癌,鱗狀細胞%舌腫瘤%外科皮瓣
암,린상세포%설종류%외과피판
Carcinoma,squamous cell%Tongue neoplasms%Surgical flaps
目的 评价延长锁骨上岛状皮瓣(extended supraclavicular fasciocutaneous island flap,eSIF)修复舌癌术后缺损的可靠性.方法 22例经病理证实的舌癌患者,男17例,女5例,年龄26~73岁,平均(52.9±12.4)岁.应用eSIF修复,皮岛面积(4 cm×6 cm)~(8 cm×14 cm),平均5.5 cm×8.7 cm.结果 20例皮瓣成活率91%(20/22),其中2例皮瓣边缘坏死.舌外形恢复,语音、吞咽功能良好;瘢痕隐蔽,肩功能运动不受影响.随访观察5~16个月,18例生存良好;2例术后半年对侧颈淋巴结转移,经挽救性手术,目前仍存活;2例患者分别于术后8和10个月死于远处转移.结论 eSIF是修复舌癌术后缺损的可靠方法.
目的 評價延長鎖骨上島狀皮瓣(extended supraclavicular fasciocutaneous island flap,eSIF)脩複舌癌術後缺損的可靠性.方法 22例經病理證實的舌癌患者,男17例,女5例,年齡26~73歲,平均(52.9±12.4)歲.應用eSIF脩複,皮島麵積(4 cm×6 cm)~(8 cm×14 cm),平均5.5 cm×8.7 cm.結果 20例皮瓣成活率91%(20/22),其中2例皮瓣邊緣壞死.舌外形恢複,語音、吞嚥功能良好;瘢痕隱蔽,肩功能運動不受影響.隨訪觀察5~16箇月,18例生存良好;2例術後半年對側頸淋巴結轉移,經輓救性手術,目前仍存活;2例患者分彆于術後8和10箇月死于遠處轉移.結論 eSIF是脩複舌癌術後缺損的可靠方法.
목적 평개연장쇄골상도상피판(extended supraclavicular fasciocutaneous island flap,eSIF)수복설암술후결손적가고성.방법 22례경병리증실적설암환자,남17례,녀5례,년령26~73세,평균(52.9±12.4)세.응용eSIF수복,피도면적(4 cm×6 cm)~(8 cm×14 cm),평균5.5 cm×8.7 cm.결과 20례피판성활솔91%(20/22),기중2례피판변연배사.설외형회복,어음、탄인공능량호;반흔은폐,견공능운동불수영향.수방관찰5~16개월,18례생존량호;2례술후반년대측경림파결전이,경만구성수술,목전잉존활;2례환자분별우술후8화10개월사우원처전이.결론 eSIF시수복설암술후결손적가고방법.
Objective To assess the reliability and usefulness of the extended supraclavicular fasciocutaneous island flap (eSIF)for reconstructing soft tissue defects followinng tongue cancer ablation.Methods Twenty-two tongue defects in 22 patients with tongue cancer were repaired with eSIF after resection of the tongue malignant tumours. The sizes of the skin paddle ranged from ( 4 cm× 6 cm ) to (8 cm× 14 cm)( average: 5.5 cm × 8.7 cm). Results The eSIF survived in twenty cases, including two cases with minimal partial necrosis. The patients were follwed up for 5-16 months. Eighteen patients were alive with disease free,two were alive with disease and two died of a lung and liver metastasis. Conclusions The eSIF is reliable for reconstructing oral defects following the ablation of advanced oral malignant tumors.